Special Issue "RNA Therapeutics: From Concepts to Applications"
A special issue of Non-Coding RNA (ISSN 2311-553X).
Deadline for manuscript submissions: closed (31 October 2021).
Interests: posttranscriptional gene regulation; RNA-binding proteins; non-coding RNA; translational control; ribonomics
Special Issues, Collections and Topics in MDPI journals
RNA has moved into the spotlight as a promising target and effector for therapeutic intervention. While a variety of RNA-targeting approaches have already been developed and evaluated, recent breakthroughs with small non-coding RNAs and RNA-based vaccines showcase the great potential and nurture further development and expansion of RNA therapeutic approaches.
For this Special Issue, we welcome the contribution of research or review manuscripts in the broad area of RNA therapeutics. This could cover (i) the development, testing, and delivery of small antisense oligonucleotides and/or antagomirs for gene expression modulation and correction; (ii) the screening, validation, delivery and efficacy testing of small molecules/drugs that interfere with or consolidate RNA-RNA or RNA-protein interactions; (iii) the implementation of long ncRNA (lncRNA) and mRNA for therapeutics; and (iv) recent progress in the delivery of RNAs to particular cells/tissues. Critical reviews that highlight the advantages and disadvantages of RNA therapeutic approaches, including provocative statements and opinions on future developments are also particularly welcome.
Essentially, this Special Issue shall provide a broad perspective of current approaches and future developments in RNA therapeutics, with an emphasis on ncRNAs as a target or drug for therapeutic intervention and eventual curation of human disease.
Prof. Dr. André P. Gerber
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Non-Coding RNA is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Gene therapy
- antisense oligonucleotides
- small molecules
- drug development
- RNA-RNA interactions
- RNA-protein interactions
- RNA processing
- human disease